Cystadenocarcinoma

Cystadenocaryoma is a malignant tumor that develops from epithelial cells that form cysts or sacs. It can be found in different parts of the body, including the ovaries, breasts, liver, lungs and other organs.

Cystadenocaryomas can be of different types, depending on what cells they are made of. The most common types are epithelial tumors, which are formed from cells that form cysts. These tumors can be either benign or malignant.

One of the most common types of cystadenokiarcoma is ovarian cystadenocarcinoma, which occurs in the ovaries. It can occur in both women and men. Ovarian cystadenocardacinoma can lead to the development of ovarian cancer, which is one of the most common types of cancer in women.

Treatment for cystadenocarcacioma depends on its type and stage of development. In some cases, surgical removal of the tumor may be necessary, but chemotherapy, radiation therapy, or a combination of treatments may also be used. The prognosis for patients with cystadenocarcioma can vary depending on the type of tumor and its stage of development.

**Cistadenocarzyma** is a malignant tumor that arises in the human body from the epithelium of the appendages, usually the ovaries, less commonly the mammary glands or fallopian tubes. Also, cystadenomas arise - cystadenovesicomas, formed from the transitional epithelium of the glands.

The tumor begins as a result of the accumulation of kinetic cells in the ovaries - cells consisting of many nuclei and a large number of nuclear-cytoplasmic vacuoles. The tumor originates from follicular cells and is therefore also called fibroadenoma. The diagnosis is made after examination and biopsy. The prognosis of cystadenosarcomas is not as favorable as that of ovarian adenomas and can account for about 50% of the five-year survival rate. They are generally divided into serous cystadenism (the most common variant) and mucersulous carcinoma. Ongogenesis of tumor cells determines sensitivity to treatment. Serous cystadenes are sensitive to castration but not resistant to chemotherapy. This may be the reason for the removal of the uterus and appendages due to hyperplastic processes in the mammary gland. Mucerous carcinomas, on the contrary, respond resistant to hormonal drugs, but are susceptible to surgery. Considering this fact, removal of the uterus and appendages is indicated. Surgery is performed not only to remove the tumor, but also the ovaries as a whole. It is preferable to perform the operation laparoscopically. The purpose of surgery is to more completely remove the primary lesion and prevent metastases.